91 related articles for article (PubMed ID: 28971150)
1. Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma.
Iwagami Y; Casulli S; Nagaoka K; Kim M; Carlson RI; Ogawa K; Lebowitz MS; Fuller S; Biswas B; Stewart S; Dong X; Ghanbari H; Wands JR
Heliyon; 2017 Sep; 3(9):e00407. PubMed ID: 28971150
[TBL] [Abstract][Full Text] [Related]
2. Multi-organ metastasis as destination for breast cancer cells guided by biomechanical architecture.
Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Liu D; Bai X; Sun B; Hung MC; Liu L; Wands JR; Dong X
Am J Cancer Res; 2021; 11(6):2537-2567. PubMed ID: 34249415
[TBL] [Abstract][Full Text] [Related]
3. Aspartate β-hydroxylase Regulates Expression of
Kanwal M; Smahelova J; Ciharova B; Johari SD; Nunvar J; Olsen M; Smahel M
J Cancer; 2024; 15(5):1138-1152. PubMed ID: 38356711
[No Abstract] [Full Text] [Related]
4. Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8
Arab A; Nicastro J; Slavcev R; Razazan A; Barati N; Nikpoor AR; Brojeni AAM; Mosaffa F; Badiee A; Jaafari MR; Behravan J
Immunol Res; 2018 Feb; 66(1):200-206. PubMed ID: 29143917
[TBL] [Abstract][Full Text] [Related]
5. Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice.
Razazan A; Nicastro J; Slavcev R; Barati N; Arab A; Mosaffa F; Jaafari MR; Behravan J
Sci Rep; 2019 Feb; 9(1):2221. PubMed ID: 30778090
[TBL] [Abstract][Full Text] [Related]
6. Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors.
Brewitz L; Tumber A; Pfeffer I; McDonough MA; Schofield CJ
Sci Rep; 2020 May; 10(1):8650. PubMed ID: 32457455
[TBL] [Abstract][Full Text] [Related]
7. Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer.
Bartolacci C; Andreani C; Curcio C; Occhipinti S; Massaccesi L; Giovarelli M; Galeazzi R; Iezzi M; Tilio M; Gambini V; Wang J; Marchini C; Amici A
Cancer Immunol Res; 2018 Dec; 6(12):1486-1498. PubMed ID: 30327365
[TBL] [Abstract][Full Text] [Related]
8. Phage based vaccine: A novel strategy in prevention and treatment.
Mohammad Hasani S; Ghafouri E; Kouhpayeh S; Amerizadeh F; Rahimmanesh I; Amirkhani Z; Khanahmad H
Heliyon; 2023 Sep; 9(9):e19925. PubMed ID: 37809683
[TBL] [Abstract][Full Text] [Related]
9. Engineered Phage-Based Cancer Vaccines: Current Advances and Future Directions.
Ragothaman M; Yoo SY
Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37243023
[TBL] [Abstract][Full Text] [Related]
10. A Recombinant RBD-Based Phage Vaccine Report: A Solution to the Prevention of New Diseases?
Salehi Z; Rasaee MJ
Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112745
[TBL] [Abstract][Full Text] [Related]
11. Disarm The Bacteria: What Temperate Phages Can Do.
Zhou S; Liu Z; Song J; Chen Y
Curr Issues Mol Biol; 2023 Feb; 45(2):1149-1167. PubMed ID: 36826021
[TBL] [Abstract][Full Text] [Related]
12. Bacteriophage-Mediated Cancer Gene Therapy.
Petrov G; Dymova M; Richter V
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430720
[TBL] [Abstract][Full Text] [Related]
13. Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-Hydroxylase.
Wirsching S; Fichter M; Cacicedo ML; Landfester K; Gehring S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293298
[TBL] [Abstract][Full Text] [Related]
14. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
15. Bacteriophages as Solid Tumor Theragnostic Agents.
Veeranarayanan S; Azam AH; Kiga K; Watanabe S; Cui L
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008840
[TBL] [Abstract][Full Text] [Related]
16. Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target.
Holtzman NG; Lebowitz MS; Koka R; Baer MR; Malhotra K; Shahlaee A; Ghanbari HA; Bentzen SM; Emadi A
Front Oncol; 2021; 11():783744. PubMed ID: 35004304
[TBL] [Abstract][Full Text] [Related]
17. Bio-nanoparticle based therapeutic vaccine induces immunogenic response against triple negative breast cancer.
Bai X; Zhou Y; Lin Q; Huang CK; Zhang S; Carlson RI; Ghanbari H; Sun B; Wands JR; Dong X
Am J Cancer Res; 2021; 11(9):4141-4174. PubMed ID: 34659881
[TBL] [Abstract][Full Text] [Related]
18. Bacteriophages as Potential Tools for Use in Antimicrobial Therapy and Vaccine Development.
Zalewska-Piątek B; Piątek R
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33916345
[TBL] [Abstract][Full Text] [Related]
19. Phages in vaccine design and immunity; mechanisms and mysteries.
de Vries CR; Chen Q; Demirdjian S; Kaber G; Khosravi A; Liu D; Van Belleghem JD; Bollyky PL
Curr Opin Biotechnol; 2021 Apr; 68():160-165. PubMed ID: 33316575
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
